Success Story: NIW Approved! Our Expert Team Positioned Immuno-Oncology Research on Innate Immune Pathways for Success

Posted by wegreened on March 20, 2026 in NIW, Biology (Pathology and Immunology, Human Genetics, Genomics, Molecular Biology, Animal, Plant, Microbiology, Genetics, Botany)

Client’s Testimonial:

"Thank you again for your excellent support throughout the process."

On January 22^nd, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Postdoctoral Research Fellow in the Field of Immuno-Oncology (Approval Notice).

General Field: Immuno-Oncology

Position at the Time of Case Filing: Postdoctoral Research Fellow

Country of Origin: India

State of Residence at the Time of Filing: Massachusetts

Approval Notice Date: January 22^rd, 2026

Processing Time: 10 months, 2 days (Premium Processing Upgrade Requested)

Case Summary:

The hard question in cancer immunotherapy is why some patients benefit while others do not, and how clinicians can identify targets that translate into durable responses. The client’s work sits in that space, investigating innate immune pathways to enhance immunotherapy and uncover novel therapeutic targets, with a specific focus on T-cell malignancies and the development of new treatment strategies for T-cell lymphoma.

For NIW, the most persuasive cases tend to look less like a list of credentials and more like a coherent story with verifiable signals. The problem has clear national importance, the proposed work is technically grounded and feasible, and the record shows real field reliance. North America Immigration Law Group (Chen Immigration Law Associates) built the filing around those signals, showing that the client’s contributions form a sustained, connected research direction in immuno-oncology.

A Cohesive Research Direction in Precision Immunotherapy The client holds a Ph.D. in biochemistry and proposed to continue research on investigating and targeting innate immune pathways to enhance cancer immunotherapy and identify new therapeutic targets, specifically in T-cell malignancies. We framed this endeavor as an area of clear, substantial merit and national importance because improving immunotherapy effectiveness and expanding actionable targets can directly support better cancer outcomes and reduce the broader burden cancer places on U.S. healthcare systems.

Objective Indicators of Impact and Trust We organized the evidence so USCIS could quickly verify influence through objective indicators:

Peer-review activity: at least 30 completed reviews, reflecting repeated trust in the client’s judgment and expertise
Publication record: 15 peer-reviewed journal articles (3 first-authored), demonstrating sustained output in the field
Citation reliance: 768 citations, showing that other researchers have relied on the client’s findings and methods
Selective dissemination: publication in highly regarded, top-ranked peer-reviewed journals in oncology and molecular biology
Field-normalized influence: multiple articles with top-percentile citation performance for their publication years, helping interpret impact without relying on raw totals alone

These metrics were not treated as self-explanatory. The petition tied them to how the research community functions. Repeated selection by highly ranked journals indicates consistent success under rigorous peer review. Citations show independent reliance, meaning other teams used the client’s work as a foundation for their own investigations. Continued peer-review invitations serve as a professional trust signal, since journals typically select reviewers with proven expertise and reliable technical judgment. Percentile-based citation evidence further helps an adjudicator evaluate influence fairly across different publication years.

The Result USCIS approved the NIW petition, recognizing a record shaped by a nationally important endeavor, clear positioning through advanced training and ongoing U.S.-based research activity, and objective evidence of influence and professional trust through selective publication, independent citation reliance, and sustained peer-review service. We congratulate the client on this important milestone and look forward to the client’s continued contributions to improving cancer immunotherapy and expanding treatment options for T-cell malignancies in the United States.

--------------------------------------------

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Sixty-four Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With nearly 64,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Tens of Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to nearly 64,000 in 2025.

Track Record of Success EB-1 and NIW Approvals

(2012.01 - 2025.12)

Category	Approval or Refund^®		Approval or Refiling^TM
	Approval or Refund^®
Category	Approved Sum	Success Rate	Approved Sum	Success Rate
NIW	42,047	99%	5,258	97%
EB1A	9,218	91%	4,534	86%
EB1B	1,488	98%	448	93%
Total	52,753	98%	10,240	92%